Mark Froimson, Director at Pacira BioSciences, Inc. (PCRX), bought 1,400 shares at $11.58 ($16K) on 2024-08-12, disclosed to the SEC on 2024-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PCRX | SELL | 2021-03-17 | $106K | — | Filing → |
| PCRX | BUY | 2017-08-16 | $4K | — | Filing → |